GO FUND IT NOW

CASE WESTERN RESERVE UNIVERSITY

Highly selective targeted theranostics for prostate cancers

Highly selective targeted theranostics for prostate cancers is a funding opportunity from CASE WESTERN RESERVE UNIVERSITY, up to 634753, closing July 31, 2026.

Funder
CASE WESTERN RESERVE UNIVERSITY
Funding
634753
Deadline
Jul 31, 2026
(0d left)

Overview

Abstract. Prostate cancer (PCa) is the most common malignancy and the second leading cause of cancer death in men in the United States. Although surgery and radiation therapy in patients with low risk disease appear appropriate and effective, those with high-risk localized disease almost always become hormone…

Highly selective targeted theranostics for prostate cancers | Go Fund It Now